3 Healthcare Stocks That Are Undeniably Dirt Cheap Right Now

Even in the midst of a market that many view as overpriced, inexpensive stocks can be found. One valuation metric that I like to use to find these potential bargains is the enterprise value-to-EBITDA ratio.

The first component of this metric -- enterprise value (EV) -- is calculated by adding market cap plus debt, minority interest, and preferred shares, then subtracting total cash and cash equivalents. EV represents what it would actually cost to buy a company outright, which makes it more useful than just market cap or stock price.

The second component of the metric is EBITDA -- earnings before interest, taxes, depreciation, and amortization. One advantage to using EBITDA instead of net income is that it isn't affected by how a company finances its balance sheet (for example, through debt, issuing equity, or both).

A low EV-to-EBITDA measurement is a pretty good indicator that a stock is relatively cheap. And there are three healthcare stocks that are undeniably dirt cheap right now based on the metric: United Therapeutics (NASDAQ:UTHR), Gilead Sciences (NASDAQ:GILD), and Humana (NYSE:HUM). But are these cheap stocks smart picks to buy?

Image source: Getty Images.

1. United Therapeutics

United Therapeutics claims a super-low EV-to-EBITDA ratio of 3.98. You won't find many stocks that are less expensive using the metric. But why is the biotech so cheaply priced?

A lot of United Therapeutics' low valuation stems from the threats the company faces from generic competition. Pulmonary arterial hypertension (PAH) drugs Remodulin and Adcirca generated $671 million and $420 million in sales, respectively, in 2017. Revenue from these drugs will probably fall with generic versions�likely to reach the market this summer.�

The biotech does have three other approved drugs -- Tyvaso, Orenitram, and Unituxin. However, these drugs combined contributed less than 37% of United Therapeutics' total revenue last year. Also, the patents for Tyvaso are being challenged by a leading generic-drug maker.�

United Therapeutics' pipeline includes seven candidates that could win approval over the next three years. Five of these candidates are new formulations or combinations of the company's existing drugs. It remains to be seen if these drugs can turn things around for United Therapeutics.��

2. Gilead Sciences

Gilead Sciences' EV-to-EBITDA ratio currently stands at 6.39. This value is well below that of other big biotechs in Gilead's peer group. As is the case with United Therapeutics, though, there's an easily identifiable reason behind Gilead's low valuation.

For Gilead, that reason is sinking hepatitis C virus (HCV) product sales. The biotech once enjoyed staggering growth, thanks to its HCV franchise. Gilead is largely a victim of its own success, though. So many patients were cured that there are fewer patients remaining who need treatment. In addition, Gilead now has a formidable rival in the HCV market with AbbVie.

Despite these HCV woes, however, there are several reasons to think that the future could be brighter for Gilead. The biotech's management team thinks that HCV sales will stabilize. Gilead recently launched new HIV drug Biktarvy, which is practically a sure bet for becoming a megablockbuster success.�

The company's pipeline could also help Gilead's fortunes improve in the not-too-distant future. Two candidates that especially stand out are selonsertib, which targets treatment of non-alcoholic steatohepatitis (NASH), and autoimmune disease drug filgotinib.�

3. Humana

Humana claims an EV-to-EBITDA ratio of 6.97. The big health insurer's main rivals are much more expensive. The primary reason behind Humana's relatively low valuation can be found on its balance sheet.

While Humana's market cap is around $40 billion, the company's enterprise value is less than $26 billion. Why this big gap? Humana's cash stockpile, including cash, cash equivalents, and marketable securities, totaled $18.6 billion at the end of the first quarter. The company's total debt was only $5.3 billion.

At least one deep-pocketed investor seems to find Humana's valuation attractive. The Wall Street Journal reported last month that Walmart�was in early talks about acquiring Humana. There are several reasons the huge retail company could be interested in moving into health insurance. So far, though, no final deal has been announced.

Even if Walmart doesn't buy Humana, the health insurer appears to be in solid shape. Humana's Medicare Advantage business is booming. After posting great Q1 results earlier this month, the company upped its full-year 2018 earnings guidance.��

But are they buys?

Just because something is cheap doesn't mean you should buy it. Sometimes, the low valuation should instead be a warning sign to stay away.

I think that's the case with one of these stocks. United Therapeutics faces huge challenges that I suspect will cause its stock to drop even more.�However, my view is that it's a different story for Gilead Sciences and Humana.

The ingredients are there for Gilead to make a comeback. I think that stabilization in the company's HCV sales is a matter of when -- rather than if. I like the prospects for Biktarvy and for Gilead's pipeline.�I also like Humana's position in the marketplace. An acquisition by Walmart seems like a smart move in my opinion.�

All three of these healthcare stocks are cheap for a reason. But I predict that Gilead and Humana will only be cheap for a season.

Hot Dividend Stocks To Invest In 2018

tags:GPC,UNH,BOOM,

As we close out 2017, it’s good to remind ourselves of what worked, and what didn’t. This past year, though, makes this introspective exercise rather tricky. Although Wall Street early on forecasted a rough 2017, the end result was quite the opposite. Benchmark indices hit all-time records, while most sectors witnessed tremendous optimism. Who needs dividend stocks at a time like this?

This also means that inferior investment strategies were masked by secular bullishness. The new year may not be as forgiving, which is why I’m recommending investors to get selective. Fortunately, with dividend stocks, you don’t have to feel pressured into always picking winners.

At its core, choosing the right dividend stocks to buy is about options. Although picking high-flying growth companies is the sexiest endeavor, it isn’t always the smartest. With passive-income yielding firms, you get the potential for making capital gains, and also residual payouts to bolster your position. During a down period, dividends can also help you ride out the storm.

Hot Dividend Stocks To Invest In 2018: Genuine Parts Company(GPC)

Advisors' Opinion:

• [By ]

  Genuine Parts Co. (NYSE: GPC)
  Ok, now I know I've definitely locked in the broken record award. GPC is better known to consumers as NAPA auto parts. And aftermarket auto parts is probably one of the most lucrative businesses in the United States for too many reasons to cover now.

• [By Shane Hupp]

  Bruderman Asset Management LLC lessened its stake in shares of Genuine Parts (NYSE:GPC) by 37.9% in the 1st quarter, Holdings Channel reports. The firm owned 4,091 shares of the specialty retailer’s stock after selling 2,495 shares during the quarter. Bruderman Asset Management LLC’s holdings in Genuine Parts were worth $368,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

• [By Joseph Griffin]

  Get a free copy of the Zacks research report on Genuine Parts (GPC)

  For more information about research offerings from Zacks Investment Research, visit Zacks.com

• [By ]

  2. Price To Sales�
  Another useful metric is the price-to-sales ratio (P/S). P/S measures a company's market cap versus its annual revenue number. The idea is that the lower the number, the greater the implied value. For example, Snap, Inc. (Nasdaq: SNAP) trades at 26.9 times sales, an incredibly expensive number. However, aftermarket auto parts giant Genuine Parts (NYSE: GPC) trades at just 0.88 times sales -- 88 cents to every dollar of sales the company brings in. Often, the lower the number, the more inefficiently the market has mispriced the stock.

• [By Ethan Ryder]

  DekaBank Deutsche Girozentrale lessened its position in shares of Genuine Parts (NYSE:GPC) by 64.0% during the 1st quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 11,092 shares of the specialty retailer’s stock after selling 19,733 shares during the quarter. DekaBank Deutsche Girozentrale’s holdings in Genuine Parts were worth $1,065,000 at the end of the most recent reporting period.

Hot Dividend Stocks To Invest In 2018: UnitedHealth Group Incorporated(UNH)

Advisors' Opinion:

• [By Paul Ausick]

  UnitedHealth Group Inc. (NYSE: UNH) traded down 0.80% at $224.07. The stock’s 52-week range is $156.09 to $231.77. Volume was about 40% below the daily average of around 3 million shares. The company had no specific news Wednesday

• [By Dan Caplinger]

  Health insurance giant UnitedHealth Group (NYSE:UNH) has done an admirable job of navigating the ever-changing landscape of healthcare reform over the past several years. The company was slow to embrace the health insurance exchanges set out in the Affordable Care Act, and that helped leave UnitedHealth less vulnerable when the Trump administration sought to repeal and replace Obamacare. Even as many focused on the positives of tax reform, UnitedHealth had to find ways to navigate the return of the excise tax on health insurance premiums in 2018 without seeing a material negative impact to its bottom line.

• [By Chris Lange]

  UnitedHealth Group Inc. (NYSE: UNH) is scheduled to share its quarterly report on Tuesday as well. The consensus estimates are $2.91 in EPS on $54.8 billion in revenue. Shares were last seen at $224.28. The stock has a 52-week range of $164.96 to $250.79, and the consensus price target is $271.67.

• [By Paul Ausick]

  UnitedHealth Group Inc. (NYSE: UNH) traded up 1.73% at $233.18. The stock’s 52-week range is $166.65 to $250.79. Volume was about 60% below the daily average of around 3.5 million shares. The company had no specific news.

Hot Dividend Stocks To Invest In 2018: Dynamic Materials Corporation(BOOM)

Advisors' Opinion:

• [By Lisa Levin]

  DMC Global Inc. (NASDAQ: BOOM) shares shot up 23 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.

  Shares of eHealth, Inc. (NASDAQ: EHTH) got a boost, shooting up 16 percent to $18.64 as the company posted upbeat Q1 results.

• [By Lisa Levin]

  DMC Global Inc. (NASDAQ: BOOM) shares shot up 25 percent to $39.55 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.

  Shares of Knowles Corporation (NYSE: KN) got a boost, shooting up 15 percent to $12.83 as the company reported Q1 results.

• [By Lisa Levin]

  DMC Global Inc. (NASDAQ: BOOM) shares shot up 26 percent to $39.85 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.

  Shares of eHealth, Inc. (NASDAQ: EHTH) got a boost, shooting up 19 percent to $19.04 as the company posted upbeat Q1 results.

• [By Lisa Levin] Gainers Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8. Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica. DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance. eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results. Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results. SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results. Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results. Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36. Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday. ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial. Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70. Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday. Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
• [By Lisa Levin] Gainers Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 15.3 percent to $2.41 in pre-market trading after declining 25.09 percent on Thursday. Expedia Group, Inc. (NASDAQ: EXPE) shares rose 10.7 percent to $117.75 in pre-market trading after the company reported stronger-than-expected earnings for its first quarter on Thursday. DMC Global Inc. (NASDAQ: BOOM) rose 10.6 percent to $35.00 in pre-market trading after reporting Q1 results. Genprex, Inc. (NASDAQ: GNPX) rose 10.2 percent to $12.12 in pre-market trading after climbing 86.76 percent on Thursday. Sprint Corporation (NYSE: S) shares rose 7 percent to $6.42 in pre-market trading on reports that the company has made progress on merger talks with T-Mobile. Amazon.com, Inc. (NASDAQ: AMZN) rose 6.9 percent to $1,621.95 in pre-market trading after the company posted upbeat results for its first quarter. The company sees second quarter operating income of $1.1 billion - $1.9 billion and sales of $51 billion - $54 billion. Riot Blockchain, Inc. (NASDAQ: RIOT) shares rose 5.5 percent to $7.88 in pre-market trading after gaining 1.49 percent on Thursday. Intel Corporation (NASDAQ: INTC) rose 5.3 percent to $55.86 in pre-market trading as the company reported better-than-expected results for its first quarter and also raised its FY18 sales outlook. 8x8, Inc. (NASDAQ: EGHT) rose 5.3 percent to $21.00 in pre-market trading. Southwestern Energy Company (NYSE: SWN) shares rose 5.1 percent to $4.75 in pre-market trading as the company reported better-than-expected earnings for its first quarter. Diamond Offshore Drilling, Inc. (NYSE: DO) rose 5 percent to $20.24 in pre-market trading. Baidu, Inc. (NASDAQ: BIDU) rose 4.5 percent to $249.50 in pre-market trading following upbeat Q1 profit. Charter Communications, Inc. (NASDAQ: CHTR) rose 4.3 percent to $311 in pre-market trading. Charter is expected to release quarterly earnings today. SINA Corporation (NASDAQ: SINA) shares rose 3.9 pe

General Mills' 30% Upside Looks Appetizing

Top brands that command premium pricing and customer loyalty can create significant competitive advantages over peers. General Mills, Inc (NYSE: GIS) offers a portfolio of leading brands and recently acquired high-growth pet food leader Blue Buffalo. Center-store weakness persists, but trading at 5-year lows and showing nearly 30 percent upside General Mills looks attractive for value investors. The Power of a Brand

When Warren Buffett began practicing Benjamin Graham's style of value investing, he didn't give much thought to brands or business quality. Graham's net-net strategy (stocks selling for less than net current assets) inherently provided the margin of safety that value investors require.

It was only when Charlie Munger introduced Buffett to the idea of the power of brands that Buffett tweaked his style. One of Buffett's well-known successes with the investment shift was See's Candies. To understand the power of See's brand, Buffett once explained:

"If you give your girlfriend See's Candy and she kisses you, we've got you for life."

Later, Buffett recognized a similar brand loyalty from The Coca-Cola Co (NYSE: KO) customer:

"If you gave me $100 billion and said take away the soft drink leadership of Coca-Cola in the world, I'd give it back to you and say it can't be done."

That degree of brand power is rare, of course. Still, searching for solid brands at an attractive stock price was how Buffett evolved as a value investor.

Today's value investors might consider consumer packaged foods leader General Mills, Inc. (NYSE: GIS). General Mills offers a portfolio of well-known brands and finbox.io valuation models show nearly 30 percent upside.

The General Mills Business Model

General Mills' generated $15.6 billion in consolidated net sales with an additional $1.0 billion from its proportionate share of joint venture net sales ($0.8 billion from Cereal Partners Worldwide and $0.2 billion from Häagen-Dazs Japan). The company is managed under four operating segments: North America Retail (65 percent fiscal 2017 net sales), Convenience Stores & Foodservice (12 percent), Europe & Australia (12 percent) and Asia & Latin America (11 percent). Products are split among five global categories including snacks, ready-to-eat cereal, convenient meals, yogurt, and super-premium ice cream:

Source: General Mills 2017 Annual Report

General Mills sells its products through retail stores and supplies products to the North American foodservice and commercial baking industries. Popular brands include Cheerios, Wheaties, Betty Crocker, Green Giant, Pillsbury, Haagen-Dazs, and Yoplait. Walmart Inc. (NYSE: WMT) represented 20 percent of the company's 2017 consolidated net sales and 29 percent of its North America Retail segment.

Latest Quarterly Results, "Moat" Analysis, and Growth Outlook

Third-Quarter Results

In its third quarter, General Mills posted a 1 percent increase in organic net sales and net sales increased 2 percent to $3.9 billion. The North America Retail unit sales were up 1 percent compared to the previous year. Results were helped by the Canada operating unit (6 percent increase), U.S. snacks (3 percent), and U.S. Meals & Baking (2 percent), but were pressured by U.S. Yogurt (-8 percent) and cereal (-1 percent).

Management cited increases in freight and commodity costs as weighing on its adjusted diluted EPS of $0.79 (an 8 percent increase in constant currency). To help offset these costs, strategic initiatives include increasing freight carriers and alternative transportation as well as optimizing the distribution network and its administrative structure.

The General Mills "Moat"

As management works to trim costs, General Mills' strong lineup of brands and wide scale look to continue to give it a competitive advantage over peers. Cheerios, Honey Nut Cheerios, and Cinnamon Toast Crunch are all top-5 leading brands in ready-to-eat cereal. Leading brands including Old El Paso, Haagen-Dazs, Yoplait, and Pillsbury round out the rest of General Mills' categories. The quality of these brands can command pricing power and superior shelf space over peers. General Mills' wide distribution lowers unit costs versus smaller peers and its larger scale helps to maximize advertising's impact. In all, it seems General Mills has built a significant competitive advantage versus its peers.

Sources of Growth

This isn't to say that General Mills and other packaged food companies aren't facing challenges. Center-store weakness (as customers move to fresher foods on the perimeter) has taken its toll. To compensate, management plans to reinvest in its brands and new products. Its acquisition of Blue Buffalo, while at a premium price, should also provide some support to top-line growth while supporting General Mills' overall moat. Blue Buffalo is the leader (30 percent+ market share) in the U.S. pet food's wholesome natural segment with 12 percent sales growth and a 25 percent EBITDA margin. Also helping margins is management's targeting of $750 million in annual savings (including $50 million Blue Buffalo synergies).

Estimating Generals Mills' Intrinsic Value

While Buffett moved on from Graham's net-net strategy to buying quality brands, he still required his investments to trade at a reasonable discount, or margin of safety. Buffett held over this principle to provide protection against unfavorable business developments.

So does General Mills offer much in the way of a margin of safety? It sure looks like it. Wall Street analysts expect low single-digit revenue growth to ramp up into the high-single digits with steady EBITDA margin expansion:

Source: General Mills 5-Year DCF Model, finbox.io

Incorporating these projections across nine finbox.io valuation models generates an average fair value of $53.53 per share. That estimate implies nearly 30 percent upside to current trading levels:

Source: finbox.io

That's more upside compared to General Mills' direct peers and its dividend yield also compares favorably:

Risks:

Greater-than-expected weakness in the center store could weigh on General Mills' top line. Volatile commodity costs and increased competition from incumbents and smaller players also pose risks. The Blue Buffalo integration and capturing the targeted $50M in synergies could also prove challenging.

General Mills Conclusion:

With a portfolio of leading brands and a recent acquisition of another, General Mills offers the high-quality brands that value investors seek out. Though customers have prioritized perimeter store offerings of late, brand reinvestment and new product development look to support the top line. With a 4.7 percent dividend yield and 30 percent upside, it's time value investors give General Mills another look.

Photo Credit: General Mills 2017 Annual Report

Author: Andy Pai

Expertise: financial modeling, mergers & acquisitions

Andy is also a founder at finbox.io, where he's focused on building tools that make it faster and easier for investors to do investment research. Andy's background is in investment banking where he led the analysis on over 50 board advisory engagements involving mergers and acquisitions, fairness opinions and solvency opinions. Some of his board advisory highlights:

Sears Holdings Corp.'s $620 mm spin-off via rights offering of Sears Outlet, Hometown Stores and Sears Hardware Stores. Cerberus Capital Management's $3.3 bn acquisition of SUPERVALU Inc.'s New Albertsons, Inc. assets.

Andy can be reached at andy@finbox.io.

As of this writing, I did not hold a position in any of the aforementioned securities and this is not a buy or sell recommendation on any security mentioned.

day trading futures

tags:GLMD,CHK,QNST,PF,

Samsung�(NASDAQOTH:SSNLF) Electronics recently reported its financial results for the first quarter of 2018. Samsung Electronics is a large conglomerate that consists of many different businesses, but the one that many consumers, and even investors, focus on is its mobile device business, which is the largest smartphone maker in the world by unit shipment volumes.

Last quarter, Samsung's mobile business performed quite well, with revenue up 23% year over year and operating profit up 82%. The company attributes this strong performance to the early launch of its flagship smartphones, the Galaxy S9 and Galaxy S9 Plus, as well as continued sales of its prior-generation Galaxy S8 series devices.

Image source: Samsung.

However, in the coming quarter, Samsung says that it expects a decline in the profitability of its mobile business caused by "stagnant sales of flagship models amid weak demand and an increase in marketing expenses to address the situation."�

day trading futures: Galmed Pharmaceuticals Ltd.(GLMD)

Advisors' Opinion:

• [By Shane Hupp]

  Here are some of the media stories that may have effected Accern’s rankings:

  Get Galmed Pharmaceuticals alerts: Galmed Pharmaceuticals’ (GLMD) CEO Allen Baharaff on Q1 2018 Results – Earnings Call Transcript (seekingalpha.com) What You Must Know About Galmed Pharmaceuticals Ltd��s (NASDAQ:GLMD) Market Risks (finance.yahoo.com) Obeticholic Acid Market Analysis, Recent Trends and Regional Growth Forecast by Types, Applications and Economic … (theexpertconsulting.com) oholic Steatohepatitis (NASH) Market 2023: Know Marketing Channel Future Trend, Growth and Price with Future … (theexpertconsulting.com) Umbilical Cord Blood May Offer Early FH Diagnosis (medscape.com)

  A number of equities analysts have recently commented on GLMD shares. ValuEngine lowered shares of Galmed Pharmaceuticals from a “hold” rating to a “sell” rating in a report on Wednesday, February 14th. Maxim Group set a $14.00 price target on shares of Galmed Pharmaceuticals and gave the stock a “buy” rating in a report on Wednesday, May 9th. Finally, HC Wainwright lifted their price target on shares of Galmed Pharmaceuticals from $18.00 to $24.00 and gave the stock a “buy” rating in a report on Monday, February 12th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The company currently has an average rating of “Buy” and an average price target of $20.40.

day trading futures: Chesapeake Energy Corporation(CHK)

Advisors' Opinion:

• [By Paul Ausick]

  Chesapeake Energy Corp. (NYSE: CHK) dropped more than 10% Friday to post a new 52-week low of $2.53 after closing at $2.82 on Thursday. The stock’s 52-week high is $6.59. Volume was around 55 million, almost double the daily average of about 30 million. The company had no specific news, but tumbling oil & natural gas prices simply punish this stock.

• [By Paul Ausick]

  Here’s how share prices of the largest U.S. natural gas producers reacted to today’s report:

  Exxon Mobil Corp. (NYSE: XOM), the country’s largest producer of natural gas, traded down about 2.4%, at $80.21 in a 52-week range of $72.16 to $89.30. Chesapeake Energy Corp. (NYSE: CHK) traded down about 1.8%, at $4.55 in a 52-week range of $2.53 to $5.68. EOG Resources Inc. (NYSE: EOG) traded down about 2.1% to $120.38. The 52-week range is $81.99 to $128.03.

  Also, the United States Natural Gas ETF (NYSEARCA: UNG) traded up about 0.3%, at $23.99 in a 52-week range of $20.40 to $29.96.

• [By Paul Ausick]

  Chesapeake Energy Corp. (NYSE: CHK) dropped about 4.6% Friday to match a 52-week low of $3.30 after closing at $3.46 on Thursday. The stock’s 52-week high is $6.65. Volume was around 35 million, about 25% above the daily average of around 28.8 million. The company had no specific news.

• [By Logan Wallace]

  Chesapeake Energy (NYSE:CHK) – Analysts at Jefferies Group boosted their Q2 2019 earnings per share estimates for shares of Chesapeake Energy in a research note issued to investors on Tuesday, May 15th. Jefferies Group analyst M. Lear now forecasts that the oil and gas exploration company will post earnings per share of $0.10 for the quarter, up from their prior estimate of $0.09. Jefferies Group also issued estimates for Chesapeake Energy’s Q1 2020 earnings at $0.22 EPS and FY2020 earnings at $0.86 EPS.

• [By Lisa Levin] Gainers SenesTech, Inc. (NASDAQ: SNES) shares surged 296.07 percent to close at $1.25 on Monday after the California Department of Pesticide Regulation proposed to register the company's ContraPest for sale and use in California. AgEagle Aerial Systems, Inc. (NASDAQ: UAVS) shares gained 19.59 percent to close at $2.93. TransGlobe Energy Corporation (NASDAQ: TGA) rose 18.39 percent to close at $2.64 on Monday. Sears Hometown and Outlet Stores, Inc. (NASDAQ: SHOS) shares gained 15.91 percent to close at $2.55. VAALCO Energy, Inc. (NYSE: EGY) shares jumped 14.9 percent to close at $2.39. Resonant Inc. (NASDAQ: RESN) climbed 13.96 percent to close at $4.49. Chesapeake Energy Corporation (NYSE: CHK) shares rose 13.55 percent to close at $4.61 on Monday. Lilis Energy, Inc. (NYSE: LLEX) surged 13.09 percent to close at $5.01. MB Financial, Inc. (NASDAQ: MBFI) gained 12.9 percent to close at $49.28. Fifth Third Bancorp (NASDAQ: FITB) agreed to acquire MB Financial for $54.70 per share in cash and stock. TransEnterix, Inc. (NYSE: TRXC) shares rose 12.83 percent to close at $3.43. World Wrestling Entertainment, Inc. (NYSE: WWE) jumped 12.52 percent to close at $57.86 on Reports that it has reached a deal with Fox for Its 'Smackdown Live' program. Eastman Kodak Company (NASDAQ: KODK) rose 12.38 percent to close at $5.90. NuCana plc (NASDAQ: NCNA) climbed 11.94 percent to close at $26.44. NuCana appointed Dr. Cyrille Leperlier to its Board as an independent non-executive Director. Aqua Metals, Inc. (NASDAQ: AQMS) rose 11.83 percent to close at $3.97 on Monday. Huami Corporation (NYSE: HMI) shares jumped 11.27 percent to close at $10.17 following Q1 results. 21Vianet Group, Inc. (NASDAQ: VNET) gained 9.55 percent to close at $7.34. Boxlight Corporation (NASDAQ: BOXL) rose 8.56 percent to close at $7.86 after the company announced an exclusive partnership with Multi Touch Interactives to strengthen the de

day trading futures: QuinStreet, Inc.(QNST)

Advisors' Opinion:

• [By Joseph Griffin]

  QuinStreet (NASDAQ:QNST) Director James R. Simons sold 229,718 shares of the company’s stock in a transaction on Thursday, May 17th. The stock was sold at an average price of $12.39, for a total transaction of $2,846,206.02. The sale was disclosed in a legal filing with the SEC, which can be accessed through the SEC website.

• [By Dan Caplinger]

  The mood was negative on Wall Street on Wednesday, and most major benchmarks finished in the red. Strength in the technology sector wasn't enough to lift more cyclically focused benchmarks like the Dow Jones Industrial Average, and the combination of an attack on Saudi Arabia that sent oil prices higher and some disquieting readings on the inflation front kept investors from feeling more confident about stocks going into earnings season. In addition, some individual companies had bad news that sent their shares lower. Analogic (NASDAQ:ALOG), QuinStreet (NASDAQ:QNST), and MSC Industrial Direct (NYSE:MSM) were among the worst performers on the day. Here's why they did so poorly.

day trading futures: Pinnacle Foods, Inc.(PF)

Advisors' Opinion:

• [By Ethan Ryder]

  Synovus Financial Corp acquired a new stake in shares of Pinnacle Foods (NYSE:PF) in the first quarter, HoldingsChannel reports. The fund acquired 2,094 shares of the company’s stock, valued at approximately $113,000.

• [By Ethan Ryder]

  Pinnacle Foods (NYSE:PF) had its target price increased by Deutsche Bank from $61.00 to $66.00 in a report issued on Friday. Deutsche Bank currently has a buy rating on the stock.

• [By Logan Wallace]

  Pinnacle Foods (NYSE:PF) – Research analysts at Jefferies Group dropped their Q2 2018 EPS estimates for Pinnacle Foods in a research report issued on Tuesday, May 8th. Jefferies Group analyst A. Jagdale now forecasts that the company will post earnings per share of $0.56 for the quarter, down from their prior forecast of $0.58. Jefferies Group currently has a “Buy” rating and a $72.00 target price on the stock. Jefferies Group also issued estimates for Pinnacle Foods’ Q1 2019 earnings at $0.62 EPS, Q2 2019 earnings at $0.62 EPS, Q3 2019 earnings at $0.76 EPS, Q4 2019 earnings at $1.15 EPS, FY2019 earnings at $3.16 EPS and FY2020 earnings at $3.44 EPS.

• [By Shane Hupp]

  Pinnacle Foods (NYSE:PF) last posted its earnings results on Thursday, May 3rd. The company reported $0.57 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.56 by $0.01. Pinnacle Foods had a net margin of 17.93% and a return on equity of 14.39%. The firm had revenue of $778.83 million for the quarter, compared to analyst estimates of $767.94 million. During the same period in the previous year, the firm posted $0.50 EPS. The company’s revenue for the quarter was up 1.7% compared to the same quarter last year. equities research analysts predict that Pinnacle Foods will post 2.89 EPS for the current year.

• [By Jeremy Bowman]

  Shares of�Pinnacle Foods Inc.�(NYSE:PF) were moving higher in April after the packaged-foods company became a target of activist investor Jana Partners. As a result the stock finished the month up 12%, according to data from S&P Global Market Intelligence.�

Fairfield Bush & CO. Decreases Stake in Lowe’s (LOW)

Fairfield Bush & CO. lessened its position in shares of Lowe’s (NYSE:LOW) by 13.1% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 130,412 shares of the home improvement retailer’s stock after selling 19,578 shares during the quarter. Lowe’s makes up about 3.3% of Fairfield Bush & CO.’s investment portfolio, making the stock its 5th largest position. Fairfield Bush & CO.’s holdings in Lowe’s were worth $11,444,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in the company. TCI Wealth Advisors Inc. boosted its stake in Lowe’s by 10.6% in the 4th quarter. TCI Wealth Advisors Inc. now owns 5,021 shares of the home improvement retailer’s stock valued at $467,000 after buying an additional 483 shares in the last quarter. Harel Insurance Investments & Financial Services Ltd. boosted its stake in Lowe’s by 50.0% in the 4th quarter. Harel Insurance Investments & Financial Services Ltd. now owns 1,500 shares of the home improvement retailer’s stock valued at $139,000 after buying an additional 500 shares in the last quarter. Barnett & Company Inc. boosted its stake in Lowe’s by 13.6% in the 4th quarter. Barnett & Company Inc. now owns 4,183 shares of the home improvement retailer’s stock valued at $389,000 after buying an additional 500 shares in the last quarter. River Wealth Advisors LLC boosted its stake in Lowe’s by 2.7% in the 4th quarter. River Wealth Advisors LLC now owns 19,529 shares of the home improvement retailer’s stock valued at $1,815,000 after buying an additional 514 shares in the last quarter. Finally, Good Life Advisors LLC boosted its stake in Lowe’s by 13.8% in the 4th quarter. Good Life Advisors LLC now owns 4,341 shares of the home improvement retailer’s stock valued at $407,000 after buying an additional 528 shares in the last quarter. 72.83% of the stock is currently owned by institutional investors.

Get Lowe's alerts:

A number of equities analysts have commented on the company. Morgan Stanley set a $115.00 price objective on Lowe’s and gave the stock a “buy” rating in a research note on Monday, January 22nd. Stifel Nicolaus reissued a “buy” rating and issued a $105.00 price objective on shares of Lowe’s in a research note on Thursday, March 1st. Deutsche Bank set a $107.00 price objective on Lowe’s and gave the stock a “buy” rating in a research note on Thursday, March 1st. Jefferies Group raised Lowe’s from a “hold” rating to a “buy” rating and boosted their price objective for the stock from $81.00 to $129.00 in a research note on Monday, February 5th. Finally, Zacks Investment Research raised Lowe’s from a “hold” rating to a “buy” rating and set a $116.00 price objective on the stock in a research note on Friday, February 2nd. One research analyst has rated the stock with a sell rating, ten have assigned a hold rating and twenty-four have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $99.00.

Lowe’s opened at $87.39 on Tuesday, according to Marketbeat. The stock has a market capitalization of $71.66 billion, a P/E ratio of 19.91, a P/E/G ratio of 0.91 and a beta of 1.33. The company has a quick ratio of 0.11, a current ratio of 1.06 and a debt-to-equity ratio of 2.65. Lowe’s has a 12 month low of $70.76 and a 12 month high of $108.98.

Lowe’s (NYSE:LOW) last released its quarterly earnings data on Wednesday, February 28th. The home improvement retailer reported $0.74 EPS for the quarter, missing analysts’ consensus estimates of $0.87 by ($0.13). The company had revenue of $15.49 billion during the quarter, compared to the consensus estimate of $15.34 billion. Lowe’s had a net margin of 5.02% and a return on equity of 65.17%. The company’s revenue for the quarter was down 1.8% compared to the same quarter last year. During the same quarter in the prior year, the company posted $0.86 EPS. equities research analysts predict that Lowe’s will post 5.46 EPS for the current year.

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 9th. Investors of record on Wednesday, April 25th were issued a $0.41 dividend. The ex-dividend date of this dividend was Tuesday, April 24th. This represents a $1.64 dividend on an annualized basis and a yield of 1.88%. Lowe’s’s dividend payout ratio is presently 37.36%.

Lowe’s announced that its board has approved a share repurchase plan on Friday, January 26th that authorizes the company to repurchase $5.00 billion in shares. This repurchase authorization authorizes the home improvement retailer to buy shares of its stock through open market purchases. Stock repurchase plans are typically a sign that the company’s management believes its stock is undervalued.

About Lowe’s

Lowe's Companies, Inc, together with its subsidiaries, operates as a home improvement retailer in the United States, Canada, and Mexico. It offers a line of products for maintenance, repair, remodeling, and decorating. The company provides home improvement products in various categories, such as lumber and building materials, tools and hardware, appliances, fashion fixtures, rough plumbing and electrical, seasonal and outdoor living, lawn and garden, paint, millwork, flooring, and kitchens, as well as outdoor power equipment.

Want to see what other hedge funds are holding LOW? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lowe’s (NYSE:LOW).

Upcoming Earnings: Target To Report Q1 Results Wednesday

Investors will likely get an update on Target Corporation (NYSE: TGT) progress in what the company has called a “transition year” when it reports first-quarter earnings before market open on Wednesday, May 23.

In early 2017, TGT executives laid out their strategy to address customers’ evolving shopping habits. The plan largely centered around improving its digital experience, launching more exclusive brands, and remodeling existing stores and opening small-format locations.

Even though the company’s remodeling efforts are still in their early stages, there have been some analysts that have noted the company’s progress and think it has improved customer’s overall shopping experience, although there’s still uncertainty if it has started to impact the business in a meaningful way.

In Q4 2017, TGT’s comparable sales grew 3.6 percent year over year, and management said it expects comp sales growth in the low-single digits in 2018. On average, analysts are forecasting 2.8 percent year-over-year comp sales growth for Q1 2018.

Lately, the company has taken several steps aimed at improving its supply chain and digital capabilities. After acquiring same-day delivery company Shipt for $550 million in December 2017, TGT said it would roll out same-day delivery to half of its locations in early 2018 and in a majority of its stores by the 2018 holiday season.

In addition to offering same-day delivery in more markets, TGT has taken other steps to expand its fulfillment options. When it last reported, the company said it plans to increase the number of stores that offer Drive Up, which allows customers to have orders brought out to their car when they pull up to the store, from 50 to about 1,000 by the end of 2018.

Several analysts have been optimistic these steps will help bolster the company’s e-commerce growth. TGT’s digital channel sales were up 29 percent year over year in Q4 2017. At the same time, however, management has cautioned profit margins will be pressured by the rollout of new fulfillment options. 

Earnings and Revenue

TGT is expected to report adjusted EPS of $1.38, up from $1.21 in the prior-year quarter, on revenue of $16.57 billion, according to third-party consensus analyst estimates. Revenue is projected to grow 3.4 percent year over year.

When it last reported, TGT beat revenue estimates, but it missed on earnings and management’s earnings guidance was weaker than what analysts were expecting. Management said it expects adjusted EPS of $1.25 to $1.45 in Q1 and $5.15 to $5.45 for the full year.

Trading Activity

Around the upcoming earnings release, the options market has priced in about a 4.3 percent stock price move in either direction according to the Market Maker Move indicator on the thinkorswim® platform. Implied volatility was at the 39th percentile as of this morning. 

TARGET 2018 STOCK CHART. TGT bumped up against the mid-to-high $78 level twice early on in the year. After the second time hitting it at the end of February, the stock pulled back and had been trading in a narrower range from early March to early May. The stock has been rising leading up to the report and has been trading closer to its 2018 high of $78.70. Chart source: thinkorswim® by TD Ameritrade.  Not a recommendation. For illustrative purposes only. Past performance does not guarantee future results.

In short-term trading at the May 25 weekly expiration, call activity has been concentrated at the 77.5 and 78 strike prices, while put activity has been concentrated at the 75 strike. Looking at the June 15 monthly expiration, recent trading has been heavier at the 77.5 and 80 strikes on the call side, and again at the 75 strike on the put side.

Note: Call options represent the right, but not the obligation, to buy the underlying security at a predetermined price over a set period of time. Put options represent the right, but not the obligation to sell the underlying security at a predetermined price over a set period of time.

What’s Coming Up

Earnings season continues to wind down, with mostly retail and a few smaller tech companies reporting this week.

Consider keeping an eye on the FOMC minutes from the Fed’s May 1-2 meeting, scheduled for release at 2:00PM on Wednesday, the same day as TGT’s report.

The next Fed meeting is coming up on June 12-13. The futures market is currently predicting a 100 percent chance of a rate hike at that meeting, and about a 50-50 chance of four rate hikes this year. If you have time, check out today’s market update for a look at what else is going on across markets.

Information from TDA is not intended to be investment advice or construed as a recommendation or endorsement of any particular investment or investment strategy, and is for illustrative purposes only. Be sure to understand all risks involved with each strategy, including commission costs, before attempting to place any trade.

Ralph Lauren Co. (RL) Shares Sold by Tredje AP fonden

Tredje AP fonden lowered its stake in Ralph Lauren Co. (NYSE:RL) by 6.2% in the 1st quarter, according to its most recent filing with the SEC. The fund owned 16,720 shares of the textile maker’s stock after selling 1,110 shares during the period. Tredje AP fonden’s holdings in Ralph Lauren were worth $1,878,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Amalgamated Bank increased its position in shares of Ralph Lauren by 5.7% in the 4th quarter. Amalgamated Bank now owns 11,505 shares of the textile maker’s stock worth $1,193,000 after purchasing an additional 619 shares during the last quarter. Bank of Hawaii increased its position in shares of Ralph Lauren by 11.2% in the 1st quarter. Bank of Hawaii now owns 7,045 shares of the textile maker’s stock worth $788,000 after purchasing an additional 710 shares during the last quarter. Crossmark Global Holdings Inc. increased its position in shares of Ralph Lauren by 11.9% in the 4th quarter. Crossmark Global Holdings Inc. now owns 6,718 shares of the textile maker’s stock worth $697,000 after purchasing an additional 712 shares during the last quarter. O Shaughnessy Asset Management LLC bought a new stake in shares of Ralph Lauren in the 1st quarter worth about $112,000. Finally, Rhumbline Advisers increased its position in shares of Ralph Lauren by 1.1% in the 4th quarter. Rhumbline Advisers now owns 94,497 shares of the textile maker’s stock worth $9,798,000 after purchasing an additional 1,034 shares during the last quarter. 69.61% of the stock is owned by institutional investors.

Get Ralph Lauren alerts:

A number of equities research analysts recently weighed in on RL shares. Zacks Investment Research raised shares of Ralph Lauren from a “hold” rating to a “buy” rating and set a $116.00 price objective for the company in a research report on Tuesday, February 13th. ValuEngine downgraded shares of Ralph Lauren from a “buy” rating to a “hold” rating in a research report on Friday, March 23rd. Cowen raised shares of Ralph Lauren from a “market perform” rating to an “outperform” rating and lowered their price objective for the company from $119.33 to $66.06 in a research report on Thursday, March 22nd. Piper Jaffray Companies set a $109.00 price objective on shares of Ralph Lauren and gave the company a “sell” rating in a research report on Tuesday, January 30th. Finally, Credit Suisse Group started coverage on shares of Ralph Lauren in a research report on Monday, March 12th. They set an “outperform” rating and a $125.00 price objective for the company. Four analysts have rated the stock with a sell rating, nine have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of $99.00.

NYSE RL opened at $115.46 on Monday. Ralph Lauren Co. has a 52 week low of $66.06 and a 52 week high of $119.33. The company has a quick ratio of 1.58, a current ratio of 2.07 and a debt-to-equity ratio of 0.09. The stock has a market capitalization of $9.39 billion, a price-to-earnings ratio of 20.22, a PEG ratio of 1.85 and a beta of 0.63.

Ralph Lauren Profile

Ralph Lauren Corporation designs, markets, and distributes lifestyle products worldwide. The company operates in three segments: North America, Europe, and Asia. It offers apparel, including a range of men's, women's, and children's clothing; accessories, which comprise footwear, eyewear, watches, fine jewelry, hats, belts, and leather goods, such as handbags and luggage; home products consisting of bedding and bath products, furniture, fabrics and wallpapers, lightings, paints, tabletops, and giftware; and fragrances.

Top 10 High Tech Stocks To Own Right Now

tags:CDTX,VTVT,NOAH,SUN,SRE,SQM,IDTI,WCG,CPIX,DCIX, 1. Stock market overview: U.S. stock futures were a bit sluggish Monday after major indexes hit fresh record highs last week.

Asian markets closed with mixed results, and European markets also struggled to find direction.

The Dow Jones industrial average, S&P 500 and Nasdaq all rose by more than 2% over the past week to hit all-time highs.

Before the Bell newsletter: Key market news. In your inbox. Subscribe now!

2. Watching Wynn: Investors are closely monitoring shares in casino firms Wynn Macau (WYNMY) and Wynn Resorts (WYNN).

Shares in Wynn Resorts plunged more than 10% Friday after a Wall Street Journal story detailed numerous allegations of sexual misconduct against founder and CEO Steve Wynn.

Wynn denied the charges in the Journal story.

"The idea that I ever assaulted any woman is preposterous," he said in a statement that the company sent to CNN.

On Monday, Wynn Macau stock fell 6.5% in Hong Kong.

Top 10 High Tech Stocks To Own Right Now: Cidara Therapeutics, Inc.(CDTX)

Advisors' Opinion:

• [By Joseph Griffin]

  Cidara Therapeutics (NASDAQ:CDTX) issued its quarterly earnings data on Thursday. The biotechnology company reported ($0.80) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.70) by ($0.10), Bloomberg Earnings reports.

• [By Chris Lange]

  Cidara Therapeutics Inc. (NASDAQ: CDTX) shares took a big step back on Monday, despite the firm reporting positive midstage results. Specifically, Cidara reported positive topline results from its Phase 2 Strive clinical trial of its lead antifungal candidate rezafungin acetate.

Top 10 High Tech Stocks To Own Right Now: vTv Therapeutics Inc.(VTVT)

Advisors' Opinion:

• [By Lisa Levin] Gainers Turtle Beach Corporation (NASDAQ: HEAR) surged 87.1 percent to $12.98 after the company reported Q1 results and raised its FY18 outlook. ARMO BioSciences, Inc. (NASDAQ: ARMO) shares jumped 66.8 percent to $49.735 after Eli Lilly and Company (NYSE: LLY) announced plans to acquire ARMO BioSciences for $50 per share. vTv Therapeutics Inc. (NASDAQ: VTVT) gained 34 percent to $2.2920 following announcement that the company will pre-specify new subgroup with the FDA and report Phase 3 Part B results in June. Prestige Brands Holdings, Inc. (NYSE: PBH) climbed 22.3 percent to $34.84 after the company posted upbeat Q4 earnings. Depomed, Inc. (NASDAQ: DEPO) shares jumped 22.2 percent to $7.28 following better-than-expected Q1 earnings. Everspin Technologies, Inc. (NASDAQ: MRAM) gained 19.8 percent to $8.89 after the company reported strong results for its first quarter. Luxfer Holdings PLC (NYSE: LXFR) surged 19.8 percent to $17.10 following Q1 results. Clean Energy Fuels Corp. (NASDAQ: CLNE) rose 18.3 percent to $2.26 after French company Total announced plans to acquire 25 percent stake in Clean Energy Fuels for $83.4 million. Intelligent Systems Corporation (NYSE: INS) gained 17 percent to $7.116. Green Dot Corporation (NYSE: GDOT) surged 15.3 percent to $73.00 after reporting upbeat Q1 earnings. The Chefs' Warehouse, Inc. (NASDAQ: CHEF) climbed 15 percent to $28.85. Chefs' Warehouse posted Q1 earnings of $0.03 per share on sales of $318.6 million. Westport Fuel Systems Inc. (NASDAQ: WPRT) rose 14.2 percent to $2.9701. Wright Medical Group N.V. (NASDAQ: WMGI) jumped 13.8 percent to $23.87 after reporting upbeat quarterly earnings. Diplomat Pharmacy, Inc. (NYSE: DPLO) gained 13.4 percent to $22.70. Diplomat named Brian Griffin as Chairman and CEO. Carvana Co. (NYSE: CVNA) shares rose 13 percent to $27.97 after reporting upbeat Q1 sales. Prothena Corporation plc (NASDAQ: PRTA) gained 12 percent to $15.19
• [By Stephan Byrd]

  COPYRIGHT VIOLATION NOTICE: “Q1 2018 EPS Estimates for vTv Therapeutics Decreased by Seaport Global Securities (VTVT)” was first reported by Ticker Report and is the sole property of of Ticker Report. If you are viewing this report on another site, it was illegally copied and reposted in violation of United States and international copyright and trademark law. The legal version of this report can be read at https://www.tickerreport.com/banking-finance/3350631/q1-2018-eps-estimates-for-vtv-therapeutics-decreased-by-seaport-global-securities-vtvt.html.

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers Aceto Corporation (NASDAQ: ACET) fell 41.9 percent to $4.30 in pre-market trading. ACETO board disclosed that it is taking proactive steps to address business and financial challenges. Canaccord Genuity downgraded Aceto from Buy to Sell. Helios and Matheson Analytics Inc. (NASDAQ: HMNY) fell 25.3 percent to $2.86 in pre-market trading after reporting an ATM offering of $150 million. Pier 1 Imports, Inc. (NYSE: PIR) fell 17.4 percent to $2.86 in pre-market trading after reporting a fourth quarter sales miss. Comps were down 7.5 percent in the quarter. Sleep Number Corporation (NASDAQ: SNBR) fell 12.4 percent to $32.00 in pre-market trading following a first quarter earnings miss. Paratek Pharmaceuticals, Inc. (NASDAQ: PRTK) fell 10.2 percent to $11.90 in pre-market trading on news of $125 million convertible debt offering. Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK) shares fell 8 percent to $8.02 in pre-market trading after dropping 2.02 percent on Wednesday. Exponent, Inc. (NASDAQ: EXPO) shares fell 5.6 percent to $80 in pre-market trading. Lumentum Holdings Inc. (NASDAQ: LITE) shares fell 4.8 percent to $60.00 in pre-market trading after rising 1.78 percent on Wednesday. vTv Therapeutics Inc. (NASDAQ: VTVT) fell 4.6 percent to $2.10 in pre-market trading after surging 84.87 percent on Wednesday. Taiwan Semiconductor Manufacturing Company Limited (NYSE: TSM) shares fell 4.5 percent to $40.07 in pre-market trading after the company reported Q1 results. Align Technology, Inc.. (NASDAQ: ALGN) fell 3.5 percent to $267.40 in pre-market trading after rising 1.61 percent on Wednesday. Transocean Ltd. (NYSE: RIG) shares fell 3.5 percent to $12 in pre-market trading after the company issued quarterly fleet status report. GoPro, Inc. (NASDAQ: GPRO) fell 3.2 percent to $4.90 in pre-market trading. Unilever PLC (NYSE: UL) fell 2.6 percent to $54.73 in pre-market
• [By Paul Ausick]

  vTv Therapeutics Inc. (NASDAQ: VTVT) dropped about 79% Tuesday to post a new 52-week low of $0.69. Shares closed at $3.26 on Monday and the stock’s 52-week high is $8.40. Volume was about 30 times the daily average of around 205,000 shares. The company’s Alzheimer drug failed to meet the goals of a phase 3 study.

• [By Lisa Levin] Gainers vTv Therapeutics Inc. (NASDAQ: VTVT) shares surged 115 percent to $2.56. Seadrill Limited (NYSE: SDRL) gained 77 percent to $0.3935. On Tuesday, a U.S. court approved the company's plan to exit Chapter 11 bankruptcy that includes raising around $1 billion in new debt and equity through a rights offering which will be led by its biggest shareholder. DropCar, Inc. (NASDAQ: DCAR) shares climbed 21.4 percent to $2.3301 after the company issued a preliminary Q1 update on its enterprise automotive business. The company disclosed that Q1 B2B automotive volumes rose 163 percent year-over-year. Teligent, Inc. (NASDAQ: TLGT) shares jumped 19.7 percent to $3.615 following the FDA approval of Clobetasol Propionate Cream USP, 0.05%. IZEA, Inc. (NASDAQ: IZEA) surged 19.1 percent to $2.62. IZEA posted a Q4 net loss of $743,000 on sales of $6.8 million. SunPower Corporation (NASDAQ: SPWR) shares gained 15.2 percent to $9.6180. SunPower announced plans to acquire SolarWorld Americas. LexinFintech Holdings Ltd. (NASDAQ: LX) climbed 10.2 percent to $15.20. CounterPath Corporation (NASDAQ: CPAH) shares rose 8.8 percent to $3.0033. Semiconductor Manufacturing International Corporation (NYSE: SMI) gained 8.2 percent to $6.685 after falling 0.80 percent on Tuesday. Energy XXI Gulf Coast, Inc. (NASDAQ: EGC) shares climbed 7.2 percent to $5.93. Textron Inc. (NYSE: TXT) shares rose 6.7 percent to $63.96 after the company reported stronger-than-expected earnings for its first quarter. Sibanye Gold Limited (NYSE: SBGL) gained 6.5 percent to $3.59 after dropping 4.53 percent on Tuesday. Calithera Biosciences, Inc. (NASDAQ: CALA) rose 6.3 percent to $6.75 after the company disclosed that the FDA has granted Fast Track designation to CB-839 in combination with cabozantinib for treatment of patients with advanced renal cell carcinoma. CSX Corporation (NASDAQ: CSX) gained 6.1 percent to $60.01 after reporting upbeat quarterly earnings

Top 10 High Tech Stocks To Own Right Now: Noah Holdings Ltd.(NOAH)

Advisors' Opinion:

• [By Stephan Byrd]

  Noah Coin (CURRENCY:NOAH) traded down 0.2% against the US dollar during the 24-hour period ending at 10:00 AM Eastern on May 14th. Noah Coin has a market capitalization of $0.00 and approximately $2.39 million worth of Noah Coin was traded on exchanges in the last day. One Noah Coin token can currently be purchased for approximately $0.0083 or 0.00000095 BTC on cryptocurrency exchanges. Over the last seven days, Noah Coin has traded down 8.5% against the US dollar.

• [By Joseph Griffin]

  Noah Coin (CURRENCY:NOAH) traded up 4% against the US dollar during the 1 day period ending at 23:00 PM E.T. on May 18th. During the last seven days, Noah Coin has traded down 6.4% against the US dollar. One Noah Coin token can now be purchased for about $0.0079 or 0.00000096 BTC on exchanges. Noah Coin has a market cap of $0.00 and $4.58 million worth of Noah Coin was traded on exchanges in the last day.

• [By Max Byerly]

  Noah Holdings (NYSE:NOAH)’s share price hit a new 52-week high and low on Monday . The stock traded as low as $57.81 and last traded at $57.76, with a volume of 191661 shares traded. The stock had previously closed at $54.50.

Top 10 High Tech Stocks To Own Right Now: Sunoco LP(SUN)

Advisors' Opinion:

• [By Benzinga News Desk]

  President Donald Trump hinted he may intervene in the Justice Department’s Russia investigation, as a Senate panel advanced a measure to protect Special Counsel Robert Mueller: Link

  ECONOMIC DATA USA GDP (QoQ) for Q1 2.30% vs 2.00% Est; Prior 2.90% The University of Michigan's consumer confidence index for April is schedule for release at 10:00 a.m. ET. The Baker Hughes North American rig count report for the latest week will be released at 1:00 p.m. ET. Data on farm prices for the recent week will be released at 3:00 p.m. ET. ANALYST RATINGS Stifel upgraded Facebook (NASDAQ: FB) from Hold to Buy Morgan Stanley upgraded Acacia Communications (NASDAQ: ACIA) from Underweight to Equal-Weight Jefferies downgraded Sunoco (NYSE: SUN) from Hold to Underperform KBW downgraded Oaktree Capital (NYSE: OAK) from Outperform to Market Perform

  This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here.

• [By Matthew DiLallo]

  However, he did rule out the possibility that the company would also roll up its other MLP Sunoco LP (NYSE:SUN). He said that "we're very pleased with what we're seeing at SUN as far as the growth that they will be directing that MLP into. And as you know, SUN is younger in the IDR life." Because of that "for the reasonable future, we don't see that being rolled up."

• [By Matthew DiLallo]

  The only segment where earnings declined was the catch-all one labeled "all other," which houses different investments such as its stake in Sunoco L.P. (NYSE:SUN) and PES, a refining joint venture. PES has struggled due to higher costs, and recently declared bankruptcy. Meanwhile, Energy Transfer's earnings from Sunoco L.P. declined because that entity sold the bulk of its retail assets and then used that cash to repurchase a portion of Energy Transfer's investment.

• [By ]

  That's the case for Sunoco (NYSE: SUN). After posting a net loss of $0.09 per share in 2017, the gas station owner is expected to swing to a hefty profit of $2.35 per share in 2018. But of the 14 analysts who follow the company, earnings estimates range as low as $1.22 and as high as $3.35 -- so there is a high degree of uncertainty.�

• [By Stephan Byrd]

  Sunoco (NYSE: SUN) and Macquarie Infrastructure (NYSE:MIC) are both mid-cap oils/energy companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, risk, profitability, dividends, analyst recommendations, valuation and institutional ownership.

• [By Joseph Griffin]

  Sunoco (NYSE:SUN) released its quarterly earnings results on Wednesday. The oil and gas company reported ($3.74) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.57 by ($4.31), Briefing.com reports. Sunoco had a return on equity of 17.06% and a net margin of 1.27%. The firm had revenue of $3.75 billion for the quarter, compared to the consensus estimate of $3 billion. During the same quarter in the previous year, the business posted ($0.22) EPS. The firm’s revenue for the quarter was up 33.5% compared to the same quarter last year.

Top 10 High Tech Stocks To Own Right Now: Sempra Energy(SRE)

Advisors' Opinion:

• [By Logan Wallace]

  Sempra Energy (NYSE: SRE) and Vectren (NYSE:VVC) are both utilities companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations and earnings.

• [By Lisa Levin] Companies Reporting Before The Bell Tyson Foods, Inc. (NYSE: TSN) is projected to report quarterly earnings at $1.32 per share on revenue of $9.89 billion. Sysco Corporation (NYSE: SYY) is estimated to report quarterly earnings at $0.64 per share on revenue of $14.34 billion. Louisiana-Pacific Corporation (NYSE: LPX) is expected to report quarterly earnings at $0.67 per share on revenue of $692.63 million. Cognizant Technology Solutions Corporation (NASDAQ: CTSH) is estimated to report quarterly earnings at $1.06 per share on revenue of 3.90 billion. Manchester United plc (NYSE: MANU) is estimated to report quarterly loss at $1.35 per share on revenue of $193.67 million. Sempra Energy (NYSE: SRE) is expected to report quarterly earnings at $1.66 per share on revenue of $3.24 billion. Willis Towers Watson Public Limited Company (NYSE: WLTW) is projected to report quarterly earnings at $3.01 per share on revenue of $2.23 billion. Green Plains Inc. (NASDAQ: GPRE) is estimated to report quarterly loss at $0.28 per share on revenue of $922.42 million. TravelCenters of America LLC (NASDAQ: TA) is projected to report quarterly loss at $0.16 per share on revenue of $1.59 billion. Gannett Co., Inc. (NYSE: GCI) is expected to report quarterly earnings at $0.03 per share on revenue of $723.93 million. Welbilt, Inc. (NYSE: WBT) is estimated to report quarterly earnings at $0.11 per share on revenue of $329.71 million. Horizon Pharma Public Limited Company (NASDAQ: HZNP) is projected to report quarterly earnings at $0.07 per share on revenue of $234.17 million.

   

• [By Tyler Crowe]

  Sempra Energy's (NYSE:SRE) acquisition of Oncor was a bit of a coup on Wall Street, as it was able to outbid Berkshire Hathaway for the Texas utility. The victory didn't come cheap, though, as Sempra had to cough up $9.5 billion and take on quite a bit of debt in the process of completing the deal. Even though the company sees immense potential in the purchase and the growth opportunities that come with it, shares of Sempra have been mostly flat for the past year.

Top 10 High Tech Stocks To Own Right Now: Sociedad Quimica y Minera S.A.(SQM)

Advisors' Opinion:

• [By Jim Robertson]

  Bloomberg recently had an editorial about why is there so little noise about the oligopoly controlling lithium��� now one of the hottest elements on the periodic table thanks to electric vehicles (EVs). Traditionally, USA based FMC Corp (NYSE: FMC) along with�Albemarle Corporation (NYSE: ALB) and Chile��s Sociedad Quimica y Minera de Chile (NYSE: SQM) have formed�a lithium oligopoly dominating global production. The Bloomberg article�though breaks�down the lithium carbonate market as follows:

• [By Jim Robertson]

  Morgan Stanley analysts had issued a report predicting that the cost of the lithium could fall 45% by 2021 and they also downgraded key lithium producers Albemarle Corporation (NYSE: ALB) and Chile��s Sociedad Quimica y Minera de Chile (NYSE: SQM) to "underweight" from "equal weight.�� �

• [By Jim Robertson]

  Earlier this week, senior commercial vice president Daniel Jimenez of Sociedad Quimica y Minera de Chile (NYSE: SQM)�told delegates at Industrial Minerals' and Metal Bulletin's inaugural Battery Materials conference in Shanghai that there is a legitimate concern on the side of electric vehicle (EV)�manufacturers over the reliability of lithium supply sources and that the industry has shown ��poor track record of delivering projects on time.�� Jimenez also commented:

Top 10 High Tech Stocks To Own Right Now: Integrated Device Technology, Inc.(IDTI)

Advisors' Opinion:

• [By Ethan Ryder]

  Integrated Device Technology (NASDAQ:IDTI) CEO Gregory L. Waters sold 43,699 shares of the company’s stock in a transaction dated Tuesday, May 15th. The stock was sold at an average price of $30.80, for a total transaction of $1,345,929.20. Following the completion of the sale, the chief executive officer now owns 806,420 shares in the company, valued at approximately $24,837,736. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink.

• [By Ezra Schwarzbaum]

  Several other optics stocks stand to gain. In a Monday note, Bank of America Merrill Lynch analyst Vivek Arya also highlighlited the semiconductor space as one that could benefit from the news. Other stocks to watch include:

  Lumentum Holdings Inc (NASDAQ: LITE) Ciena Corporation (NYSE: CIEN) Coherent, Inc. (NASDAQ: COHR) II-VI, Inc. (NASDAQ: IIVI) Inphi Corporation (NYSE: IPHI) Skyworks Solutions Inc (NASDAQ: SWKS) Integrated Device Technology Inc (NASDAQ: IDTI) Qorvo Inc (NASDAQ: QRVO) Xilinx, Inc. (NASDAQ: XLNX) Broadcom Inc (NASDAQ: AVGO)

  Related Links:

Top 10 High Tech Stocks To Own Right Now: WellCare Helath Plans Inc.(WCG)

Advisors' Opinion:

• [By Max Byerly]

  WellCare (NYSE:WCG) had its target price boosted by Wells Fargo from $220.00 to $240.00 in a report released on Wednesday morning. Wells Fargo currently has an outperform rating on the stock.

Top 10 High Tech Stocks To Own Right Now: Cumberland Pharmaceuticals Inc.(CPIX)

Advisors' Opinion:

• [By Max Byerly]

  COPYRIGHT VIOLATION NOTICE: “Cumberland Pharmaceuticals (CPIX) Research Coverage Started at B. Riley” was originally posted by Ticker Report and is the property of of Ticker Report. If you are reading this report on another domain, it was copied illegally and republished in violation of US and international copyright & trademark legislation. The legal version of this report can be accessed at https://www.tickerreport.com/banking-finance/3364464/cumberland-pharmaceuticals-cpix-research-coverage-started-at-b-riley.html.

Top 10 High Tech Stocks To Own Right Now: Diana Containerships Inc.(DCIX)

Advisors' Opinion:

• [By Lisa Levin] Gainers Carver Bancorp, Inc. (NASDAQ: CARV) shares jumped 92.1 percent to $7.01. iPic Entertainment Inc. (NASDAQ: IPIC) gained 21.6 percent to $9.73. Baozun Inc. (NASDAQ: BZUN) shares jumped 18.7 percent to $53.49 after reporting Q1 results. World Wrestling Entertainment, Inc. (NYSE: WWE) shares jumped 15.9 percent to $50.50. The company's "Smackdown Live" may not be renewed at NBCUniversal network and the company's "Monday Night Raw" program could be worth three times its current value elsewhere, according to a report for The Hollywood Reporter. Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) gained 14.7 percent to $ 20.46 after the company issued further details on Phase 3 ADVANCE study of ROLONTIS. Motus GI Holdings, Inc. (NASDAQ: MOTS) climbed 13.4 percent to $5.5009. Endocyte, Inc. (NASDAQ: ECYT) rose 13.3 percent to $ 14.23 after the company announced presentation of Phase 2 data from prostate cancer trial of 177Lu-PSMA-617 at the 2018 ASCO Annual Meeting. Diana Containerships Inc. (NASDAQ: DCIX) gained 12.9 percent to $1.7499 after the company announced the sale of Post-Panamax Container Vessel for $21 million. Essendant Inc. (NASDAQ: ESND) gained 12.7 percent to $12.43. Essendant confirmed receipt of unsolicited proposal from Staples of $11.50 per share in cash. Blink Charging Co (NASDAQ: BLNK) rose 11.8 percent to $8.04 after surging 31.68 percent on Wednesday. OptimumBank Holdings, Inc. (NASDAQ: OPHC) gained 11.5 percent to $5.15. Flotek Industries, Inc. (NYSE: FTK) shares climbed 10.7 percent to $3.74. Farmer Bros. Co. (NASDAQ: FARM) rose 7.9 percent to $25.95 after climbing 7.90 percent on Wednesday. Minerva Neurosciences Inc (NASDAQ: NERV) rose 6.5 percent to $6.93 after Journal of Clinical Psychiatry published positive results of cognitive performance from Phase 2B trial of roluperidone in schizophrenia patients. Williams Partners L.P. (NYSE: WPZ) rose 5.6 percent to $40